FDA Approves Prior Approval Supplement for BIVIGAM®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 11.07 +0.39 (3.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.68 | 52 Week High | $9.65 | |||
| Open | $10.73 | 52 Week Low | $4.15 | |||
| Day High | $11.12 | P/E | N/A | |||
| Day Low | $10.70 | EPS | $-0.01 | |||
| Volume | 2,027,274 | |||||
